Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Open Access Guideline
Open Access Guideline
Postgraduate Thesis Guideline
Postgraduate Thesis Guideline
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
Polycomb Paralog Chromodomain Inhibitors Active against Both CBX6 and CBX8**
Download
index.pdf
Date
2021-10-01
Author
Milosevich, Natalia
Wilson, Chelsea R.
Brown, Tyler M.
Alpsoy, Aktan
Wang, Sijie
Connelly, Katelyn E.
Sinclair, Kirsten A. D.
Ponio, Felino R.
Hof, Rebecca
Dykhuizen, Emily C.
Hof, Fraser
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
10
views
4
downloads
Cite This
Methyllysine reader proteins bind to methylated lysine residues and alter gene transcription by changing either the compaction state of chromatin or by the recruitment of other multiprotein complexes. The polycomb paralog family of methyllysine readers bind to trimethylated lysine on the tail of histone 3 (H3) via a highly conserved aromatic cage located in their chromodomains. Each of the polycomb paralogs are implicated in several disease states. CBX6 and CBX8 are members of the polycomb paralog family with two structurally similar chromodomains. By exploring the structure-activity relationships of a previously reported CBX6 inhibitor we have discovered more potent and cell permeable analogs. Our current report includes potent, dual-selective inhibitors of CBX6 and CBX8. We have shown that the -2 position in our scaffold is an important residue for selectivity amongst the polycomb paralogs. Preliminary cell-based studies show that the new inhibitors impact cell proliferation in a rhabdoid tumor cell line.
URI
https://hdl.handle.net/11511/117354
Journal
CHEMMEDCHEM
DOI
https://doi.org/10.1002/cmdc.202100262
Collections
Department of Biology, Article
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
N. Milosevich et al., “Polycomb Paralog Chromodomain Inhibitors Active against Both CBX6 and CBX8**,”
CHEMMEDCHEM
, vol. 16, no. 19, pp. 3027–3034, 2021, Accessed: 00, 2025. [Online]. Available: https://hdl.handle.net/11511/117354.